Quantification in positron emission tomography for research in pharmacology and drug development

被引：25
|
作者：
Cunningham, VJ [1 ]
Gunn, RN [1 ]
Matthews, JC [1 ]
机构：
[1] Addenbrookes Hosp, ACCI, GlasoSmithKline, Translat Med & Technol, Cambridge, England
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 2004年 / 25卷 / 07期
关键词：
positron emission tomography; quantification; blood flow; metabolic rate for glucose; neuroreceptor function;
D O I：
10.1097/01.mnm.0000134330.38536.bc
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Positron emission tomography (PET) is a quantitative in vivo tracer technique, enabling images of the distribution of biochemical, physiological and pharmacological functions in living tissue, at a resolution of a few millimetres. Applications include the imaging of blood flow rate, metabolic rate and neuroreceptor distribution and function. These applications are playing an increasing role in drug development. This brief article seeks to emphasize how these applications of PET need to rest on a solid quantitative foundation. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码：643 / 646
页数：4
相关论文
共 50 条
  • [1] Positron emission tomography application to drug development and research
    Salvadori, Piero A.
    [J]. PHYSICS FOR MEDICAL IMAGING APPLICATIONS, 2007, 240 : 341 - 351
  • [2] Positron emission tomography in drug development and drug evaluation
    Paans, AMJ
    Vaalburg, W
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (16) : 1583 - 1591
  • [3] Overview of Positron Emission Tomography, Hybrid Positron Emission Tomography Instrumentation, and Positron Emission Tomography Quantification
    Kwee, Thomas C.
    Torigian, Drew A.
    Alavi, Abass
    [J]. JOURNAL OF THORACIC IMAGING, 2013, 28 (01) : 4 - 10
  • [4] Positron emission tomography in serotonergic drug development
    Andrée, B
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (01) : 90 - 91
  • [5] Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development
    Burns, HD
    Hamill, TG
    Eng, W
    Francis, B
    Fioravanti, C
    Gibson, RE
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) : 388 - 394
  • [6] The advantage of using positron emission tomography in drug research
    Farde, L
    [J]. TRENDS IN NEUROSCIENCES, 1996, 19 (06) : 211 - 214
  • [7] Positron emission tomography: Applications in drug discovery and drug development
    Wang, JL
    Maurer, L
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (11) : 1053 - 1075
  • [8] Positron emission tomography: Enabling efficient drug development via in vivio quantification of target engagement
    Hostetler, Eric
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [9] Positron emission tomography molecular imaging for drug development
    Matthews, Paul M.
    Rabiner, Eugenii A.
    Passchier, Jan
    Gunn, Roger N.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 175 - 186
  • [10] Use of positron emission tomography in anticancer drug development
    Aboagye, EO
    Price, PM
    [J]. INVESTIGATIONAL NEW DRUGS, 2003, 21 (02) : 169 - 181
12345